Comparison

VHL Antibody (N-term)

Item no. ABC-AP6549A
Manufacturer Abcepta
Amount 200 ul
Category
Type Antibody Primary
Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Applications WB, FC, IF, IHC-P
Specific against other
Host Rabbit
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Similar products VHL, pVHL, Protein G7, Von Hippel-Lindau disease tumor suppressor
Available
Primary Accession
P40337
Antigen Type
Synthetic Peptide
Application
WB, FC, IF, IHC-P
Bio Background
Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.
Bio References
Olmos, G., Cell. Mol. Life Sci. 66 (13), 2167-2180 (2009) Hatzimichael, E., Clin Lymphoma Myeloma 9 (3), 239-242 (2009) Luu, V.D., Clin. Cancer Res. 15 (10), 3297-3304 (2009)
Clonality
Polyclonal
Clone/Animal Names
RB18667
Gene ID
7428
Gene Name
VHL
Subtitle
Purified Rabbit Polyclonal Antibody (Pab)
Reactivity
H, M
Legend image 1
All lanes : Anti-VHL Antibody (N-term) at 1:1000 dilution
Lane 1: F9 whole cell lysate
Lane 2: Mouse testis lysate

Lysates/proteins at 20 µg per lane.

Secondary
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution.

Predicted band size : 24 kDa

Blocking/Dilution buffer: 5% NFDM/TBST.
Type image 1
WB
Dilution image 1
1:1000
Legend image 2
All lanes : Anti-VHL Antibody (N-term) at 1:500 dilution
Lane 1: F9 whole cell lysate
Lane 2: Mouse testis lysate


Lysates/proteins at 20 µg per lane.

Secondary
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution.

Predicted band size : 24 kDa

Blocking/Dilution buffer: 5% NFDM/TBST.
Type image 2
WB
Dilution image 2
1:500
Legend image 3
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human cervical epithelial adenocarcinoma cell line) cells labeling VHL with AP6549a at 1/25 dilution, followed by Dylight® 488-conjugated goat anti-rabbit IgG (NK179883) secondary antibody at 1/200 dilution (green). Immunofluorescence image showing nucleus and cytoplasm staining on HeLa cell line. Cytoplasmic actin is detected with Dylight® 554 Phalloidin (PD18466410) at 1/100 dilution (red). The nuclear counter stain is DAPI (blue).
Type image 3
IF
Dilution image 3
1:25
Legend image 4
Western blot analysis of VHL antibody (N-term) (Cat. #AP6549a) in HepG2 cell line lysates (35ug/lane). VHL (arrow) was detected using the purified Pab.
Type image 4
WB
Dilution image 4
1:1000
Legend image 5
Anti-VHL Antibody (N-term) at 1:2000 dilution + F9 whole cell lysate

Lysates/proteins at 20 µg per lane.

Secondary
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution.

Predicted band size : 24 kDa

Blocking/Dilution buffer: 5% NFDM/TBST.
Type image 5
WB
Dilution image 5
1:2000
Legend image 6
AP6549a staining VHL in human pancreas tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 3% BSA for 0. 5 hour at room temperature; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody (1/25) for 1 hours at 37°C. A undiluted biotinylated goat polyvalent antibody was used as the secondary antibody.
Type image 6
IHC-P
Dilution image 6
1:25
Legend image 7
AP6549a staining VHL in human kidney tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 3% BSA for 0. 5 hour at room temperature; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody (1/25) for 1 hours at 37°C. A undiluted biotinylated goat polyvalent antibody was used as the secondary antibody.
Type image 7
IHC-P
Dilution image 7
1:25
Other Accession
Q64259; P40338
Predicted
Rat
Isotype
Rabbit Ig
Calculated MW
24153
Antigen Region
43-71
Antigen Source
HUMAN
Target/Specificity
This VHL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 43-71 amino acids from the N-terminal region of human VHL.
NCBI Accession
NP_000542.1; NP_937799.1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close